Meet the Partner: MEDEA S.r.l.
MEDEA S.r.l. is the ThrombUS+ partner leading exploitation strategy, IP management, and impact assurance to bring AI-powered DVT monitoring technology […]
Videos
Partners
Project Overview
The ThrombUS+ project is focused on developing a novel wearable diagnostic device to aid in the early detection and diagnosis of deep vein thrombosis (DVT). The project integrates cutting-edge technologies, including ultrasound, artificial intelligence, light reflection rheography, plethysmography, serious games, and extended reality, to create a comprehensive and user-friendly monitoring system. ThrombUS+ aims to provide patients and healthcare professionals with real-time insights, enhancing DVT diagnosis and treatment.
The ThrombUS+ project is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 101137227 (Horizon Innovation Action | HORIZON-HLTH-2023-TOOL-05-05) and is co-funded by the European Union.
42 months
Starting Date: 1 January 2024
Ending Date: 30 June 2027
19 partners from Greece, Lithuania, France, Germany, Italy, Finland and Spain
9.5 M€ budget
co-funded by the Horizon Europe Programme
Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis
Latest Publication
ThrombUS+ in the Computational and Structural Biotechnology Journal:
News & Events
Meet the Partner: VDE
Meet VDE, ThrombUS+’s regulatory partner. Learn how VDE is embedding compliance-by-design into the development of an AI-powered wearable for early […]
Meet the Partner: Hôpital Simone Veil
Hôpital Simone Veil, the only French partner in ThrombUS+, brings cutting-edge venous thrombosis research and emergency medicine expertise to the […]
Horizon Innovation Action | Agreement No. 101137227
HORIZON-HLTH-2023-TOOL-05-05
Co-funded by the European Union
S2E2 Certified